These AIP germline mutations have been identified in 15%–20% of patients with familial isolated pituitary adenoma (FIPA) and in 3%–5% of patients with sporadic pituitary adenomas [1–5]. The gene discussed is AIP; the disease is pituitary gland adenoma.